Treating Pex2–/– mice with bile acids prolonged postnatal survival, alleviated intestinal malabsorption and intrahepatic cholestasis, and reduced production of toxic C27-bile acid intermediates (Keane et al., 2007). Here, PEX2 is linked to intrahepatic cholestasis.